Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 1,235 | 1,367 | 1,847 | 1,421 | 1,077 |
| Cost of Goods | 619 | 583 | 793 | 671 | 456 |
| Gross Profit | 616 | 784 | 1,054 | 750 | 621 |
| Operating Expenses | 1,395 | 1,343 | 1,520 | 1,409 | 1,163 |
| Operating Income | -160 | 24 | 327 | 13 | -86 |
| Other Income | 237 | -13 | 44 | -24 | -8 |
| Pre-tax Income | 77 | 11 | 371 | -11 | -94 |
| Income Tax | 20 | 4 | 166 | 6 | -31 |
| Net Income Continuous | 57 | 7 | 204 | -17 | -64 |
| Net Income | $57 | $7 | $204 | $-17 | $-64 |
| EPS Basic Total Ops | 0.02 | 0.00 | 0.07 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | 0.02 | 0.00 | 0.07 | -0.01 | -0.02 |
| EPS Diluted Total Ops | 0.02 | 0.00 | 0.07 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | 0.02 | 0.00 | 0.07 | 0.00 | -0.02 |
| EBITDA(a) | $-62 | $123 | $425 | $108 | $9 |